Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.60 -0.07 (-2.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) EBITDA Margin (2016 - 2024)

Updated

Kiora Pharmaceuticals (KPRX) recorded EBITDA Margin of 28.27% in FY2024.

Analysis

Kiora Pharmaceuticals (KPRX) EBITDA Margin (2016 - 2024) Analysis & Trends

Starting with FY2016, Kiora Pharmaceuticals' EBITDA Margin history includes 6 years.

  • Annual EBITDA Margin has a five-year change of +287.00 percentage points (FY2019 to FY2024).
  • The FY2024 figure is the highest annual EBITDA Margin in data going back to FY2016.
  • Per Business Quant data, KPRX's EBITDA Margin was -56683.55% in FY2020 (-56424.82 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -12,692.79%
Mar 31, 2024 82.67%
Dec 31, 2020 -9,623.70%
Mar 31, 2019 31.33%
Sep 30, 2018 -1,007.39%
Jun 30, 2018 -1,152.98%
Mar 31, 2018 -216.34%
Sep 30, 2017 -5,536.53%
Jun 30, 2017 -2,240.38%
Mar 31, 2017 -1,579.71%
Sep 30, 2016 -1,231.02%
Jun 30, 2016 -1,630.83%
API Access

Kiora Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KPRX&period=max&api_key=YOUR_API_KEY